Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nisarg Joshi

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Therapeutic Delivery|March 29, 2021
Letter to the Editor: "Docetaxel and its nanoformulations: how delivery strategies could impact the therapeutic outcome?"Mujtaba A Khan, Nisarg Joshi, Imran Ahmad
Oncotargets and Therapy|August 14, 2019
Nanosomal docetaxel lipid suspension based chemotherapy in a pregnant MBC patient - a case reportRajkumar Ramaswamy, Nisarg Joshi, Mujtaba A Khan, et al.
Clinical & Experimental Ophthalmology|September 2, 2021
Corneal epithelial toxicity induced by belantamab mafodotinSavan V Patel, Nisarg Joshi, Tarika Thareja, et al.
Expert Opinion on Drug Delivery|June 29, 2019
Letter to the editor: 'current advances in development of new docetaxel formulations'Mujtaba A Khan, Nisarg Joshi, Alok Chaturvedi, et al.
The Journal of Physical Chemistry. A|September 5, 2023
Efficient 3D Molecular Design with an E(3) Invariant Transformer VAEOrion Dollar, Nisarg Joshi, Jim Pfaendtner, et al.
Annual Review of Chemical and Biomolecular Engineering|March 12, 2021
Data Science in Chemical Engineering: Applications to Molecular ScienceChowdhury Ashraf, Nisarg Joshi, David A C Beck, et al.
Chemical Science|July 5, 2021
Attention-based generative models for <i>de novo</i> molecular designOrion Dollar, Nisarg Joshi, David A C Beck, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 15, 2021
Biweekly DoceAqualip in mCRPC patients beyond 20 cycles: A case seriesSrikant Tiwari, Abhaya Bisaria, Harmeet Kaur, et al.
Molecular and Clinical Oncology|July 1, 2021
Efficacy and safety of nanosomal docetaxel lipid suspension based chemotherapy in metastatic ovarian carcinoma: A retrospective studySundaram Subramanian, Aseem Samar, Nisarg Joshi, et al.
Prostate Cancer|December 31, 2020
A Multicentric, Retrospective Efficacy and Safety Study of Nanosomal Docetaxel Lipid Suspension in Metastatic Castration-Resistant Prostate CancerAseem Samar, Srikant Tiwari, Sundaram Subramanian, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Therapeutic Delivery|March 29, 2021
Letter to the Editor: "Docetaxel and its nanoformulations: how delivery strategies could impact the therapeutic outcome?"Mujtaba A Khan, Nisarg Joshi, Imran Ahmad
Oncotargets and Therapy|August 14, 2019
Nanosomal docetaxel lipid suspension based chemotherapy in a pregnant MBC patient - a case reportRajkumar Ramaswamy, Nisarg Joshi, Mujtaba A Khan, et al.
Clinical & Experimental Ophthalmology|September 2, 2021
Corneal epithelial toxicity induced by belantamab mafodotinSavan V Patel, Nisarg Joshi, Tarika Thareja, et al.
Expert Opinion on Drug Delivery|June 29, 2019
Letter to the editor: 'current advances in development of new docetaxel formulations'Mujtaba A Khan, Nisarg Joshi, Alok Chaturvedi, et al.
The Journal of Physical Chemistry. A|September 5, 2023
Efficient 3D Molecular Design with an E(3) Invariant Transformer VAEOrion Dollar, Nisarg Joshi, Jim Pfaendtner, et al.
Annual Review of Chemical and Biomolecular Engineering|March 12, 2021
Data Science in Chemical Engineering: Applications to Molecular ScienceChowdhury Ashraf, Nisarg Joshi, David A C Beck, et al.
Chemical Science|July 5, 2021
Attention-based generative models for <i>de novo</i> molecular designOrion Dollar, Nisarg Joshi, David A C Beck, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 15, 2021
Biweekly DoceAqualip in mCRPC patients beyond 20 cycles: A case seriesSrikant Tiwari, Abhaya Bisaria, Harmeet Kaur, et al.
Molecular and Clinical Oncology|July 1, 2021
Efficacy and safety of nanosomal docetaxel lipid suspension based chemotherapy in metastatic ovarian carcinoma: A retrospective studySundaram Subramanian, Aseem Samar, Nisarg Joshi, et al.
Prostate Cancer|December 31, 2020
A Multicentric, Retrospective Efficacy and Safety Study of Nanosomal Docetaxel Lipid Suspension in Metastatic Castration-Resistant Prostate CancerAseem Samar, Srikant Tiwari, Sundaram Subramanian, et al.
Pageof 2